The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Treatment of Growing Teratoma Syndrome
Open accessAbstract
gests, approaches to the same challenges around the world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the phase 1 experience, a partial response was achieved in a patient with growing teratoma syndrome (73), with clinical benefit later confirmed in a larger group of patients with teratoma (74): stable disease was noted in 19 of 74 patients with advanced solid tumors, with nine patients receiving ten or more cycles on either the 3/1 or 2/1 schedule.”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the Cell Cycle: A New Approach to Cancer Therapy
Schwartz, G. K., & Shah, M. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5594 · Cited by 817
Logothetis, C. J., Samuels, M. L., Trindade, A., & Johnson, D. E. (1982) · Cancer · doi:10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1 · Cited by 552
Surgical Management of Growing Teratoma Syndrome: The M. D. Anderson Cancer Center Experience
Spiess, P. E., Kassouf, W., Brown, G. A., Kamat, A. M., Liu, P., Gómez, J. A., Tu, S., Tannir, N. M., & Pisters, L. L. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.11.086 · Cited by 106
Deregulation of the RB pathway in human testicular germ cell tumours
Bártková, J., Lukas, C., Sørensen, C. S., Meyts, E. R., Skakkebæk, N. E., Lukas, J., & Bártek, J. (2003) · The Journal of Pathology · doi:10.1002/path.1353 · Cited by 57
Anger, B., Oettgen, H. F., Old, L. J., Bockman, R. S., Andreeff, M., Erlandson, R. A., Saigo, P. E., Jhanwar, S. C., Kameya, T., Wright, W., et al. (1982) · Cancer · doi:10.1002/1097-0142(19821015)50:8<1462::aid-cncr2820500804>3.0.co;2-1 · Cited by 38
O'Dwyer, P. J., Eckhardt, S., Haller, D. G., Tepper, J. E., Ahnen, D. J., Hamilton, S. R., Benson, A. B., Rothenberg, M. L., Petrelli, N. J., Lenz, H. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6900 · Cited by 27
Cited by
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
Dean, J. L., Thangavel, C., McClendon, A. K., Reed, C. A., & Knudsen, E. S. (2010) · Oncogene · doi:10.1038/onc.2010.154 · Cited by 393
Flaherty, K. T., LoRusso, P. M., DeMichele, A., Abramson, V. G., Courtney, R., Randolph, S. S., Shaik, M. N., Wilner, K. D., O'Dwyer, P. J., & Schwartz, G. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0509 · Cited by 366
Self-citation
Metadata
- Authors
- Vaughn, D. J., Flaherty, K., Lal, P., Gallagher, M., O'Dwyer, P., Wilner, K., Chen, I., & Schwartz, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-01-22
- Volume
- 360
- Issue
- 4
- Pages
- 423-424
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2038616177
- Cited by
- 82
- References
- 5
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 11 · 2013: 7 · 2012: 7
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Teratomas and Epidermoid Cysts
- Health Sciences › Medicine › Surgery › Testicular diseases and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- growing teratoma syndrome, teratoma, germ cell tumors
- MeSH terms
- Adult, Antineoplastic Agents, Humans, Male, Neoplasms, Germ Cell and Embryonal, Piperazines, Pyridines, Teratoma, Retinoblastoma Protein, Neoplasms, Second Primary, Disease Progression, Cyclin-Dependent Kinases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Growing Teratoma Syndrome. https://app.cochat.ai/papers/10.1056/nejmc0808558
- The paper
- Vaughn, D. J., Flaherty, K., Lal, P., Gallagher, M., O'Dwyer, P., Wilner, K., Chen, I., & Schwartz, G. (2009). Treatment of Growing Teratoma Syndrome. New England Journal of Medicine. https://doi.org/10.1056/nejmc0808558
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.